Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
10.8M
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
1.4M
-
Shares change
-
+60.4K
-
Total reported value, excl. options
-
$15.6M
-
Value change
-
+$675K
-
Number of buys
-
15
-
Number of sells
-
-4
-
Price
-
$11.18
Significant Holders of Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) as of Q3 2021
23 filings reported holding LTRN - Lantern Pharma Inc. - Common Stock, par value $0.0001 per share as of Q3 2021.
Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.4M shares
of 10.8M outstanding shares and own 12.98% of the company stock.
Largest 10 shareholders include Corriente Advisors, LLC (626K shares), VANGUARD GROUP INC (271K shares), GWM Advisors LLC (156K shares), GEODE CAPITAL MANAGEMENT, LLC (57K shares), MORGAN STANLEY (47.9K shares), Redmond Asset Management, LLC (47.4K shares), WOLFF WIESE MAGANA LLC (35.3K shares), Bank of New York Mellon Corp (26.8K shares), RAYMOND JAMES & ASSOCIATES (25.9K shares), and STATE STREET CORP (25.6K shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.